Adjuvant therapy

Association Between Genomic Recurrence Risk and Well-Being Among Breast Cancer Patients

PUBLICATION: BMC Cancer. 2013 Jun 18;13:295. doi: 10.1186/1471-2407-13-295. AUTHORS: Retรจl Read More

2024-03-25T10:45:47-04:00June 18th, 2013|Adjuvant, Evidence, MammaPrint, MINDACT, Other|

A Prospective Evaluation of a Breast Cancer Prognosis Signature in the Observational RASTER Study

PUBLICATION: Int J Cancer. 2013 Aug 15;133(4):929-36. doi: 10.1002/ijc.28082. Epub Read More

2024-03-25T10:47:48-04:00January 13th, 2013|Adjuvant, Evidence, MammaPrint, RASTER|

Use of a Genomic Test (MammaPrintโ„ข) in Daily Clinical Practice to Assist in Risk Stratification of Young Breast Cancer Patients

PUBLICATION: Arch Gynecol Obstet (2011) 283: 597. https://doi.org/10.1007/s00404-010-1454-9. AUTHORS: Kunz, Read More

2024-03-25T10:56:57-04:00March 1st, 2011|Adjuvant, Evidence, MammaPrint|

Metastatic Potential of T1 Breast Cancer Can Be Predicted by the 70-gene MammaPrint Signature

PUBLICATION: Ann Surg Oncol. 2010 May;17(5):1406-13. doi: 10.1245/s10434-009-0902-x. Epub 2010 Read More

2024-03-25T11:00:58-04:00May 1st, 2010|Adjuvant, Evidence, MammaPrint|

The Predictive Value of the 70-Gene Signature for Adjuvant Chemotherapy in Early Breast Cancer

PUBLICATION: Breast Cancer Res Treat. 2010 Apr;120(3):655-61. doi: 10.1007/s10549-010-0814-2. AUTHORS:ย  Read More

2024-02-16T13:39:04-05:00March 5th, 2010|Adjuvant, Evidence|

The 70-gene Prognosis Signature Predicts Early Metastasis in Breast Cancer Patients Between 55 and 70 Years of Age

PUBLICATION: Ann Oncol. 2010 Apr;21(4):717-22. doi: 10.1093/annonc/mdp388. Epub 2009 Oct Read More

2024-03-25T11:06:57-04:00October 13th, 2009|Adjuvant, Evidence, MammaPrint|

Analysis of the MammaPrint Breast Cancer Assay in a Predominantly Postmenopausal Cohort.

PUBLICATION: Clin Cancer Res. 2008 May 15;14(10):2988-93. doi: 10.1158/1078-0432.CCR-07-4723. AUTHORS: Read More

2024-03-25T11:14:22-04:00February 10th, 2008|Adjuvant, Evidence, MammaPrint|

Use of 70-gene Signature to Predict Prognosis of Patients with Node-Negative Breast Cancer: A Prospective Community-Based Feasibility Study (RASTER)

PUBLICATION:ย  Lancet Oncol. 2007 Dec;8(12):1079-1087. doi: 10.1016/S1470-2045(07)70346-7. Epub 2007 Nov Read More

2024-03-07T10:58:08-05:00December 8th, 2007|Adjuvant, Evidence, MammaPrint, RASTER|
Go to Top